Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

Study gives new insights into how cells leverage GPCRs to control inflammation

Study gives new insights into how cells leverage GPCRs to control inflammation

Silicone breast implants may increase risk of rare adverse outcomes in women

Silicone breast implants may increase risk of rare adverse outcomes in women

Scientists get unprecedented view of brain development through high-resolution genomic map

Scientists get unprecedented view of brain development through high-resolution genomic map

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Scientists develop first DNA-based test for predicting risk of leukemia relapse

Cancer Australia releases new data on childhood cancer stage at diagnosis

Cancer Australia releases new data on childhood cancer stage at diagnosis

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

Scientists identify 'Achilles heel' of anaplastic large-cell lymphomas

New study suggests chemotherapy may cause early menopause in women with lung cancer

New study suggests chemotherapy may cause early menopause in women with lung cancer

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

New personalized cellular therapy approved for use in the European Union

New personalized cellular therapy approved for use in the European Union

People with blood cancer less likely to understand their diagnosis

People with blood cancer less likely to understand their diagnosis

Study compares T-cell signaling patterns in two different CAR designs

Study compares T-cell signaling patterns in two different CAR designs

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Researchers find STAT3 as therapeutic target for chronic active EBV infection

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Research explores relationship between personal history of infectious fever and cancer risk

Research explores relationship between personal history of infectious fever and cancer risk

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials